Cargando…

Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population

The MCF-7 line, derived in 1973 from a malignant pleural effusion, is one of the most commonly used culture models for human breast cancer. Despite its long history, MCF-7 is a surprisingly heterogeneous line. We previously showed that if MCF-7 cells were cultured for a prolonged period either in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Euphemia, Kim, Ji Eun, Askarian-Amiri, Marjan, Finlay, Graeme J., Baguley, Bruce C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960520/ https://www.ncbi.nlm.nih.gov/pubmed/24724101 http://dx.doi.org/10.1155/2014/836769

Ejemplares similares

Hormone Resistance in Two MCF-7 Breast Cancer Cell Lines is Associated with Reduced mTOR Signaling, Decreased Glycolysis, and Increased Sensitivity to Cytotoxic Drugs
por: Leung, Euphemia Yee, et al.
Publicado: (2014)

Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines
por: Leung, Euphemia Y., et al.
Publicado: (2014)

Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer
por: Hansji, Herah, et al.
Publicado: (2014)

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
por: Leung, Euphemia Y., et al.
Publicado: (2015)

Epigenetic regulation in human melanoma: past and future
por: Sarkar, Debina, et al.
Publicado: (2015)

ZFAS1: a long noncoding RNA associated with ribosomes in breast cancer cells
por: Hansji, Herah, et al.
Publicado: (2016)

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
por: Leung, Euphemia Y., et al.
Publicado: (2017)

Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer
por: Askarian-Amiri, Marjan E., et al.
Publicado: (2014)

Correction: Sarkar, D., et al. Multiple Isoforms of ANRIL in Melanoma Cells: Structural Complexity Suggests Variations in Processing. Int. J. Mol. Sci. 2017, 18, 1378
por: Sarkar, Debina, et al.
Publicado: (2018)

Multiple Isoforms of ANRIL in Melanoma Cells: Structural Complexity Suggests Variations in Processing
por: Sarkar, Debina, et al.
Publicado: (2017)

Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines
por: Kim, Ji Eun, et al.
Publicado: (2013)

Signaling Pathways in Melanogenesis
por: D’Mello, Stacey A. N., et al.
Publicado: (2016)

Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells
por: Leung, Euphemia, et al.
Publicado: (2011)

Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations
por: Leung, Euphemia Y., et al.
Publicado: (2018)

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer
por: Singleton, Dean C., et al.
Publicado: (2020)

Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival
por: D’mello, Stacey Ann N., et al.
Publicado: (2014)

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors
por: Stones, Clare J., et al.
Publicado: (2013)

Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines
por: Kim, Ji Eun, et al.
Publicado: (2012)

The Role of the Hippo Pathway in Melanocytes and Melanoma
por: Kim, Ji Eun, et al.
Publicado: (2013)

MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature
por: Adriá-Cebrián, Jose, et al.
Publicado: (2021)

Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231
por: Garbar, Christian, et al.
Publicado: (2017)

Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative
por: Reynisson, Jóhannes, et al.
Publicado: (2016)

PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas
por: Gozgit, J M, et al.
Publicado: (2007)

SNX16 negatively regulates the migration and tumorigenesis of MCF-7 cells
por: Zhang, Leilei, et al.
Publicado: (2013)

Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells
por: Wawruszak, Anna, et al.
Publicado: (2022)

First Evidence that Ecklonia cava-Derived Dieckol Attenuates MCF-7 Human Breast Carcinoma Cell Migration
por: Kim, Eun-Kyung, et al.
Publicado: (2015)

DNA-Binding Anticancer Drugs: One Target, Two Actions
por: Baguley, Bruce C., et al.
Publicado: (2021)

Proteomic Comparison of MCF-7 Tumoursphere and Monolayer Cultures
por: Morrison, Brian J., et al.
Publicado: (2012)

Cytotoxic and chemomodulatory effects of Phyllanthus niruri in MCF-7 and MCF-7(ADR) breast cancer cells
por: Abdel-Sattar, Ola E., et al.
Publicado: (2023)

Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo
por: Gründker, Carsten, et al.
Publicado: (2010)

Estrogen Inhibits the Growth of MCF‐7 Cell Variants Resistant to Transforming Growth Factor‐beta
por: Hagino, Yoshiaki, et al.
Publicado: (1988)

Coenzyme Q(0) immobilized on Magnetic Nanoparticle: Synthesis and Antitumoral Effect on Saos, MCF7 and Hela Cell Lines
por: Aboukazempour Amiri, Mohsen, et al.
Publicado: (2020)

ROCK Inhibition Activates MCF-7 Cells
por: Yang, Seungwon, et al.
Publicado: (2014)

Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182(R)-6
por: Jensen, B L, et al.
Publicado: (1999)

Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells
por: Nokhodi, Fariba, et al.
Publicado: (2022)

A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells
por: Abdelaziz, Mohammed H., et al.
Publicado: (2023)

Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications
por: Nugoli, Mélanie, et al.
Publicado: (2003)

Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome
por: Azzarito, Giovanna, et al.
Publicado: (2023)

Genetic Analysis of Microglandular Adenosis and Acinic Cell Carcinomas of the Breast Provides Evidence for the Existence of a Low-grade Triple-Negative Breast Neoplasia Family
por: Geyer, Felipe C, et al.
Publicado: (2016)

CHIP Regulates AKT/FoxO/Bim Signaling in MCF7 and MCF10A Cells
por: Lv, Yanrong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d34d5h2n18bdjm5h2rqud7vvth